Submit your research
Start your submission and get more impact for your research by publishing with us.
Explores novel approaches and diagnoses to treat immune disorders.
The official journal of the International Union of Immunological Societies (IUIS) and the most cited in its field, leading the way for research across basic, translational and clinical immunology.
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Editors
See all- PG
pietro ghezzi
Brighton and Sussex Medical School
Brighton, United Kingdom
Field Chief Editor
Frontiers in Immunology
- AA
adriana albini
European Institute of Oncology IEO (IRCCS)
Milan, Italy
Specialty Chief Editor
Cancer Immunity and Immunotherapy
- JB
josep bassaganya-riera
Landos Biopharma, Inc.
Blacksburg, United States
Specialty Chief Editor
Nutritional Immunology
- VA
vassiliki a boussiotis
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, United States
Specialty Chief Editor
Cancer Immunity and Immunotherapy
Articles
See all (43,591)Original Research
Published on 02 May 2025
B-cell immune repertoire sequencing in tobacco cigarette smoking, vaping, and chronic obstructive pulmonary disease in the COPDGene cohort
in B Cell Biology
Frontiers in Immunologydoi 10.3389/fimmu.2025.1508786Case Report
Published on 02 May 2025
Case Report: Abscopal effect in a patient with refractory metastatic hepatocellular carcinoma treated with stereotactic body radiotherapy and PD-1 inhibitor
in Cancer Immunity and Immunotherapy
Frontiers in Immunologydoi 10.3389/fimmu.2025.1536689Original Research
Published on 02 May 2025
Apolipoprotein M expression modifies the sphingolipid landscape in murine blood and lymph
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunologydoi 10.3389/fimmu.2025.1572959- 152 views
Original Research
Published on 02 May 2025
A comprehensive pan-cancer analysis of LRFN4: its potential as a prognostic biomarker and therapeutic target for immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunologydoi 10.3389/fimmu.2025.1539076- 149 views
Research Topics
See all (3,263)Submission open
Cell Fusion and Immune Regulation in Cancer and Tissue Regeneration: Emerging Paradigms and Therapeutic Implications
- Eduardo López-Collazo
- Marta Dueñas
- Laura Hurtado Navarro
- 1,699 views
- 1 article
Submission open
Next-generations of CAR-T Cell Therapy in Hematologic Malignancies
- Andrea Aroldi
- Francesco Mazziotta
- Mirko Farina
- Lorenzo Iovino
- Benedetto Bruno
Submission open
Advances in Therapeutic Cancer Vaccines-Mechanisms and development
- Hyejin Choi
- James Moon
- Cory Brennick
- Mariam George
- Jayon Lihm
Submission open
Friend or Foe? - The Role of Macrophages and Neutrophils in Liver Pathologies
- Mirja Hommel
- Lara Campana
- Nico Lachmann
- 123 views